These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2258927)

  • 1. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment specific for an influenza virus haemagglutinin and of an escape mutant of that haemagglutinin.
    Bizebard T; Mauguen Y; Petek F; Rigolet P; Skehel JJ; Knossow M
    J Mol Biol; 1990 Dec; 216(3):513-4. PubMed ID: 2258927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization and preliminary X-ray diffraction studies of complexes between an influenza hemagglutinin and Fab fragments of two different monoclonal antibodies.
    Gigant B; Fleury D; Bizebard T; Skehel JJ; Knossow M
    Proteins; 1995 Sep; 23(1):115-7. PubMed ID: 8539243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
    Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I
    Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization, preliminary X-ray diffraction study, and crystal packing of a complex between anti-hen lysozyme antibody F9.13.7 and guinea-fowl lysozyme.
    Lescar J; Riottot MM; Souchon H; Chitarra V; Bentley GA; Navaza J; Alzari PM; Poljak RJ
    Proteins; 1993 Feb; 15(2):209-12. PubMed ID: 7680133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
    Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
    Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary X-ray analysis of type B influenza virus neuraminidase complexed with antibody Fab fragments.
    Laver WG; Luo M; Bossart PJ; Babu YS; Smith C; Accavitti MA; Tulloch PA; Air GM
    Virology; 1988 Dec; 167(2):621-4. PubMed ID: 3201756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody Fab fragment crystallized with and without a peptide epitope from HIV.
    Pfeffer-Hennig S; Wessner H; Hennig M; Dauter Z; Hausdorf G; Höhne WE
    Proteins; 1993 Aug; 16(4):437-9. PubMed ID: 7689218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary crystallographic study of a complex between an Fab of a monoclonal feline peritonitis virus neutralizing antibody and its anti-idiotypic Fab.
    Ban N; Escobar C; Day J; Greenwood A; McPherson A
    J Mol Biol; 1993 Dec; 234(3):894-6. PubMed ID: 8254683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody.
    Vanlandschoot P; Beirnaert E; Dewilde S; Saelens X; Bestebroer T; De Jong J; Jou WM; Fiers W
    Virology; 1995 Oct; 212(2):526-34. PubMed ID: 7571422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary structural studies of a chorismate mutase catalytic antibody complexed with a transition state analog.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Proteins; 1994 Feb; 18(2):198-200. PubMed ID: 8159668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
    Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
    Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization of the Fab from a human monoclonal antibody against gp 41 of human immunodeficiency virus type I.
    Casale E; Wenisch E; He XM; Righetti PG; Snyder RS; Jungbauer A; Tauer C; Ruker F; Carter DC
    J Mol Biol; 1990 Dec; 216(3):511-2. PubMed ID: 2258926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary crystallographic analysis of a Fab specific for P-glycoprotein with and without bound peptide.
    Vasudevan S; Johns KL; Rose DR
    J Mol Biol; 1994 Sep; 241(5):736-8. PubMed ID: 7915332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, crystallization and preliminary X-ray analysis of a complex between the Plasmodium vivax sexual stage 25 kDa protein Pvs25 and a malaria transmission-blocking antibody Fab fragment.
    Saxena AK; Singh K; Long CA; Garboczi DN
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2054-7. PubMed ID: 15502325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rigid-body docking with mutant constraints of influenza hemagglutinin with antibody HC19.
    Cherfils J; Bizebard T; Knossow M; Janin J
    Proteins; 1994 Jan; 18(1):8-18. PubMed ID: 7511810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of a soluble form of the rat T-cell surface glycoprotein CD4 complexed with Fab from the W3/25 monoclonal antibody.
    Davis SJ; Brady RL; Barclay AN; Harlos K; Dodson GG; Williams AF
    J Mol Biol; 1990 May; 213(1):7-10. PubMed ID: 2338715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization and preliminary X-ray data for the human transthyretin-retinol-binding protein (RBP) complex bound to an anti-RBP Fab.
    Malpeli G; Zanotti G; Gliubich F; Rizzotto A; Nishida SK; Folli C; Berni R
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):276-8. PubMed ID: 10089423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 virus. 3. Selection of antigenic variations in vitro and in vivo.
    Haaheim LR
    Acta Pathol Microbiol Scand B; 1980 Dec; 88(6):341-5. PubMed ID: 6164248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, crystallization, X-ray diffraction analysis and phasing of a Fab fragment of monoclonal neuroantibody alphaD11 against nerve growth factor.
    Covaceuszach S; Cassetta A; Cattaneo A; Lamba D
    Acta Crystallogr D Biol Crystallogr; 2004 Jul; 60(Pt 7):1323-7. PubMed ID: 15213405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.